XLV vs IDNA
YTDYear to date
IDNA wins+42.5 pts
Past year
IDNA wins+39.5 pts
Fee
XLV winslower fee
Yield
XLV wins+0.7 pts
AUM
XLV144.2× more
2–2level
XLV and IDNA · year-to-date · as of Nov 4, 2026 · AUM not scored
IDNA vs S&P 500
1Y$42.47 · +1.8% last sessionDividend-adjusted total return. S&P 500 uses VOO.CompareS&P 500+ Peer avg+ Add a fund
Return1D1M3MYTD1Y ▼3Y5YMAX
Total return+1.8%−0.6%+27.4%+62.8%+69.2%+153.1%−10.7%+83.2%
Peer average+0.6%+4.0%+6.1%+21.0%+29.0%+81.2%+28.9%—
S&P 500 · VOO+0.3%−2.6%−1.7%+11.5%+11.9%+90.9%+77.5%+816.4%
iShares IDNA and Vanguard VOO · total return, dividends in · as of Nov 4, 2026
IDNA’s Holdings
TodayMRNAModerna12.8%GMAB.CO6.5%TWST6.1%REGN4.0%4502.T3.8%BAYN.DE3.7%CAI3.6%EXEL3.6%RVMD3.5%VRTX3.4%MRK3.4%ROP.SW3.3%INCY3.2%IOVA2.8%BNTX2.7%SAN.PA2.7%IBRX2.7%IPN.PA2.6%GSK.L2.6%ABCL2.5%IDYA2.3%4528.T1.4%28 more
MRNAModerna12.8%GMAB.CO6.5%TWST6.1%REGN4.0%4502.T3.8%BAYN.DE3.7%CAI3.6%EXEL3.6%RVMD3.5%VRTX3.4%MRK3.4%38 more
BiotechnologyDrug Manufacturers - GeneralDrug Manufacturers - Specialty
iShares IDNA · 50 holdings · tile size = share of the fund · as of Nov 3, 2026
All 39 Health Care ETFs
1Y| # | Trend | |||||||
|---|---|---|---|---|---|---|---|---|
| 1 | XLV | State Street Health Care Select Sector SPDRReadDesk | 0.08% | 1.4% | +20.4% | +29.7% | $49.1B | |
| 2 | VHT | Health CareReadDesk | 0.09% | 1.4% | +19.6% | +28.1% | $19.1B | |
| 3 | XBI | State Street SPDR S&P BiotechReadDesk | 0.35% | 0.4% | +27.2% | +38.1% | $10.5B | |
| 4 | IYH | U.S. HealthcareReadDesk | 0.37% | 1.0% | +19.8% | +28.6% | $4.7B | |
| 5 | IXJ | Global HealthcareReadDesk | 0.38% | 1.3% | +16.0% | +24.7% | $4.6B | |
| 6 | IHI | U.S. Medical DevicesReadDesk | 0.37% | 0.5% | −8.9% | −5.8% | $3.9B | |
| 7 | FHLC | Fidelity MSCI Health CareReadDesk | 0.08% | 1.2% | +19.7% | +28.2% | $3.5B | |
| 8 | ARKG | ARK Genomic RevolutionReadDesk | 0.75% | — | +70.9% | +59.0% | $2.2B | |
| 9 | IHE | U.S. PharmaceuticalsReadDesk | 0.37% | 1.3% | +26.9% | +42.7% | $1.6B | |
| 10 | IHF | U.S. Healthcare ProvidersReadDesk | 0.37% | 0.9% | +24.7% | +24.0% | $1.5B | |
| 11 | PBPH | Portfolio Building Block World Pharma and BiotechReadDesk | 0.13% | 0.1% | +22.5% | new | $1.2B | |
| 12 | FTXH | First Trust Nasdaq PharmaceuticalsReadDesk | 0.60% | 0.7% | +33.8% | +46.6% | $1.2B | |
| 13 | FXH | First Trust Health Care AlphaDEXReadDesk | 0.61% | 0.5% | +21.8% | +24.6% | $1.2B | |
| 14 | PPH | VanEck PharmaceuticalReadDesk | 0.36% | 1.8% | +17.0% | +30.8% | $1.1B | |
| 15 | PJP | PharmaceuticalsReadDesk | 0.58% | 0.9% | +24.5% | +34.6% | $579M | |
| 16 | BBH | VanEck BiotechReadDesk | 0.35% | 0.4% | +35.0% | +41.8% | $525M |
1–16 of 39Page 1 of 3
Health Care · current AUM · as of Nov 4, 2026
IDNA Payouts by Year
8YLatest payout, Jun 2026
$0.13
a share · twice a year
0.7% yield
0.7% yield
8 years added up
$1.70 a share
$1.70 a share
iShares IDNA · per-share distributions by ex-date · 2019–2026
IDNA’s Peers
YTD| # | Trend | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | XLV | State Street Health Care Select Sector SPDR ETFReadVersus | 0.08% | 1.4% | −0.3% | +20.4% | +29.7% | $49.1B | |
| 2 | VHT | Vanguard Health Care ETFReadVersus | 0.09% | 1.4% | −0.1% | +19.6% | +28.1% | $19.1B | |
| 3 | XBI | State Street SPDR S&P Biotech ETFReadVersus | 0.35% | 0.4% | +1.9% | +27.2% | +38.1% | $10.5B | |
| 4 | IYH | iShares U.S. Healthcare ETFReadVersus | 0.37% | 1.0% | −0.4% | +19.8% | +28.6% | $4.7B | |
| 5 | IXJ | iShares Global Healthcare ETFReadVersus | 0.38% | 1.3% | −0.5% | +16.0% | +24.7% | $4.6B | |
| 6 | IDNA | iShares Genomics Immunology and Healthcare ETFThis fund | 0.47% | 0.7% | +1.8% | +62.8% | +69.2% | $340M |
#2 of 33 this year · #21 cheapest of 39 · sorted by assetsOpen the Sectors table →
IDNA and its peer group · total return · as of Nov 4, 2026
Cards for This View
IDNA’s Top 10 Holdings
Today51.1%of IDNA sits in these 10
2GMAB.CGenmab6.51%
54502.TTakeda Pharmaceutical3.77%
6BAYN.DBayer Ag3.71%
iShares IDNA · weight in the fund · as of Nov 3, 2026
IDNA’s Holdings
TodayMRNAModerna12.8%GMAB.CO6.5%TWST6.1%REGN4.0%4502.T3.8%BAYN.DE3.7%CAI3.6%EXEL3.6%RVMD3.5%VRTX3.4%MRK3.4%ROP.SW3.3%INCY3.2%IOVA2.8%BNTX2.7%SAN.PA2.7%IBRX2.7%IPN.PA2.6%GSK.L2.6%ABCL2.5%IDYA2.3%4528.T1.4%28 more
MRNAModerna12.8%GMAB.CO6.5%TWST6.1%REGN4.0%4502.T3.8%BAYN.DE3.7%CAI3.6%EXEL3.6%RVMD3.5%VRTX3.4%MRK3.4%38 more
BiotechnologyDrug Manufacturers - GeneralDrug Manufacturers - Specialty
iShares IDNA · 50 holdings · tile size = share of the fund · as of Nov 3, 2026
IDNA vs Peer Average
YTDIDNAAvsBPeer average
1D+1.8%+0.6%
1M−0.6%+4.0%
3M+27.4%+6.1%
YTD+62.8%+21.0%
1Y+69.2%+29.0%
3Y+153.1%+81.2%
5Y−10.7%+28.9%
5–2IDNA wins
38 Health care peers · each row scaled to its leader